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0929-6646/Copyright ª 2015, Formos
CC BY-NC-ND license (http://creativeBackground/purpose: To investigate mid- to long-term outcomes in children with coronary ar-
tery fistula (CAF).
Methods: We retrospectively reviewed the medical records of patients seen between
September 1996 and August 2011. We enrolled those diagnosed with CAF via echocardiography
(Philips SONOS 7500 system and Philips IE33) or angiography. The mean follow time was
42.58  3.4 months (range, 1e166 months). For comparative purposes, participants were
grouped as acquired versus congenital, and symptomatic versus asymptomatic. We also
measured the size of the coronary artery (CA) in patients with CA dilatation (CAD).
Results: Out of 122 CAF patients, spontaneous closure was detected in 37 patients at
21.59  3.45 months after diagnosis. This timeframe did not differ between the acquired
and congenital groups (21.64  6.26 months vs. 21.57  4.15 months; p Z 0.991). Ninety pa-
tients were asymptomatic and remained so; their spontaneous closure rate was 28.89%. More-
over, 24 patients had CAD, including 17 with Kawasaki disease and seven with congenital CAF.
The CAs of all congenital-CAF-plus-CAD patients were initially > 5 mm; these patients under-
went percutaneous transcatheter intervention, and their CA sizes decreased significantly
(6.11  0.79 mm vs. 3.76  0.36 mm; p Z 0.002).
Conclusion: With the advanced sensitivity of echocardiography, CAF can be detected more
easily than ever before. Most patients with small CAFs are asymptomatic and may experience
spontaneous closure. Therefore, management of CAF depends on symptoms; if patients are
asymptomatic and have small CAFs, intervention may not be necessary, especially in acquired
cases. However, if patients present with symptoms or persistent dilatation of the proximal CA,
surgical or percutaneous closure should be performed.
Copyright ª 2015, Formosan Medical Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
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Coronary artery fistula (CAF) is a rare anomaly of the car-
diovascular system, defined as an abnormal connection be-
tween a coronary artery (CA) and a cardiac chamber or
vessel. CAF is estimated to comprise 0.2e0.4% of all
congenital heart disease cases.1 Historically, surgical closure
or interventional catheterization have been the treatment
options for patients presenting with symptoms.2e4 However,
the management of pediatric CAF patientsdparticularly
those who are asymptomaticdremains a controversial top-
ic.1,5e8 In our literature review, we found few reports
assessing the mid- to long-term outcomes of asymptomatic
pediatric patients with CAF.5,9 The aim of this study, there-
fore, was to report on these outcomes in children with CAF,
and especially in those who are asymptomatic.
Methods
Study population
We retrospectively reviewed the medical records of patients
seen between September 1996 and August 2011. We then
enrolled those who had been diagnosed as CAF using either
echocardiography (Philips SONOS 7500 system, Philips, And-
over, MA, USA since September 1996 and Philips IE33 system,
Philips, Bothell, WA, USA since July 2008) or angiography.
Two-dimensional echocardiography was performed on the
parasternal short axis view of the aorta to visualize the
diameter of the left and right coronary arteries. Color
Doppler was performed from the parasternal, apical, and
subcostal view to identify a mosaic-colored flow in any of the
four cardiac chambers or the pulmonary artery. Unusual flow
patterns were further evaluated by pulse velocity. We
confirmed CAF spontaneous closure with two additional
echocardiography examinations. During the study period,
five cardiologists interpreted the results. Our data collection
was approved by the Institutional Review Board of Chang
Gung Memorial Hospital, Kaohsiung, Taiwan. Participants
were categorized as “acquired” or “congenital” and as
“symptomatic” or “asymptomatic.” The acquired group
comprised patients with negative CAF findings on the previ-
ous echocardiography, while patients in the symptomatic
group either presented with clinical symptoms or were found
to have coronary artery dilatation (CAD). CAD was defined by
a CA dimension > þ3 standard deviations (SDs) in one of the
three proximal segments or > þ2.5 SDs in two of the three
proximal segments according to the body surface area.10
Age, sex, body weight, clinical presentations, and out-
comes were compared between the acquired and congenital
CAF groups and between the symptomatic and asymptomatic
groups. Finally, we analyzed the CA size in participants with
CAD to detect any changes after follow-up.
Statistical analysis
Data are expressed as mean  standard error. Comparisons
of clinical parameters between the two groups were per-
formed with unpaired Student t-test, Chi-square test, or
Fisher’s exact test, as appropriate. Comparisons of CA sizeafter follow-up were performed using paired Student t-
test. A p value < 0.05 was considered statistically
significant.
Results
Demographic characteristics and clinical
presentation
A total of 122 patients were enrolled in our study, based
upon the study criteria. The age of these patients ranged
from 1 day to 16 years, with a median age of 12.5 months.
Sixty-four were male and 58 were female. The mean follow
time was 42.58  3.4 months (range, 1e166 months). Ten
patients presented with clinical symptoms: seven with
chest pain, one with exercise intolerance, one with palpi-
tation, and one with endocarditis (complicated by Kawasaki
disease). In addition to these patients, 112 patients
received cardiac examination for other reasons including:
Kawasaki disease in 22 patients; prolonged fever in two
patients; pre-operation cardiac tests in five patients; pre-
maturity heart tests in five patients; Burkitt’s lymphoma
tests in one patient; follow-up of ventricular septal defect
post-surgical repair in one patient, and undiagnosed heart
murmur tests in 76 patients. Heart murmurs were detected
in 95 (77.87%) patients in our series; however, continuous
murmur and Grade 3/6 systolic murmur were detected in
only three and four patients, respectively. Electrocardio-
gram (EKG) findings consisted of left ventricular hypertro-
phy in four patients, biventricular hypertrophy in two
patients, right ventricular hypertrophy in four patients,
non-specific ST-T changes in five patients, and incomplete
right bundle branch block in three patients. Chest radiog-
raphy revealed cardiomegaly in 16 patients. Angiographic
analysis was performed in 25 patients; eight CAFs origi-
nated from the right main CA, five from the left main CA,
eight from the left anterior descending CA, and four from
multiple origins. The main pulmonary artery (MPA) was the
most common site of termination, as seen in 92 patients.
Other termination sites observed were the right pulmonary
artery (RPA), as seen in nine patients; the left pulmonary
artery, seen in one patient; the right atrium, seen in four
patients; the right ventricle, seen in five patients; the left
atrium, seen in two patients; the left ventricular outflow
tract, seen in one patient; and the coronary sinus, seen in
one patient. Spontaneous closure was detected in 37 pa-
tients and occurred 21.59  3.45 months after diagnosis.
The spontaneous closure time curve of all 122 patients is
showed in Figure 1. Eight patients underwent interven-
tional treatment, including five who underwent trans-
catheter coil occlusion, two who underwent transcatheter
device closure, and one who underwent surgical ligation.
The patients who received transcatheter coil occlusion or
surgical ligation had no residual fistula after intervention.
However, the patients who underwent transcatheter device
closure still had a small residual shunt at follow-up.
Comparison of acquired and congenital CAF groups
Twenty-three patients in our study were categorized in the
acquired CAF group. Among them, 22 experienced
Figure 1 Spontaneous closure time curve of coronary artery
fistula. During 166 months following time, spontaneous closure
was detected in 37 patients and occurred 21.59  3.45 months
after diagnosis. CAF Z coronary artery fistula.
Outcome of coronary artery fistula in children 573complications due to Kawasaki disease, and the other was
diagnosed with CAF after undergoing surgery for a ven-
tricular septal defect. When compared with patients in the
congenital CAF group, the acquired patients were found to
have no significant differences in sex, body weight, age, the
presence of cardiomegaly (cardiothoracic ratio > 0.5 on
chest radiography), abnormal EKG, or follow-up duration
(Table 1). However, the spontaneous closure rate was
higher in the acquired group (60.87% vs. 23.23%; p < 0.001)
and most of acquired CAF group were associated with Ka-
wasaki disease. All documented incidences of either a
continuous murmur or a Grade 3/6 systolic murmur
occurred in the congenital group. With regard to the 37 CAF
patients with spontaneous closure, there was no statisti-
cally significant difference in time of spontaneous CAFTable 1 Comparison of clinical manifestations of acquired and
All patients
(n Z 122)
Sex (male:female) 64:58
Body weight (kg) 12.4 ± 0.94
Age (mo) 28.17 ± 3.49
Follow-up period (mo) 42.58 ± 3.4
Continuous murmur or Grade 2-3/6
systolic murmur (yes/no)
7/115
Chest radiographya (cardiomegaly/normal) 16/62
Electrocardiographyb (abnormal/normal) 19/88
Spontaneous closure (yes/no) 37/85
Associated with Kawasaki disease (yes/no) 23/99
a 44 patients did not undergo chest radiography (acquired group, 11
b 15 patients did not undergo electrocardiography (acquired group,closure between acquired and congenital groups
(21.64  6.26 months for the acquired group vs.
21.57  4.15 months for the congenital group; p Z 0.991).Comparison of symptomatic and asymptomatic CAF
groups
Thirty-two patients were categorized in the symptomatic
group. They presented with symptoms including Kawasaki
disease with dilated CA (n Z 17), palpitation (n Z 1),
congenital CAF with dilated CA (n Z 7), and chest pain
(n Z 7). There were no significant differences in sex, body
weight, age, abnormal EKG, spontaneous closure rate, or
follow-up duration between the symptomatic and asymp-
tomatic groups (Table 2). Continuous or Grade 3/6 systolic
heart murmurs and cardiomegaly were found to be more
prevalent in the symptomatic group. We also found that the
majority of patients with acquired CAF and patients with
associated Kawasaki disease were categorized in the
symptomatic group.Comparison of clinical presentations of different
CAF drainage sites
Among 92 patients with CAF drainage into the MPA, 20.65%
were symptomatic (including Kawasaki disease with CAD in
12 patients, chest pain in 6 patients and palpitation in 1
patient), 29.35% had spontaneous resolution and 19.57%
were associated with Kawasaki disease (including CAD and
non-CAD). Among 30 patients with CAF drainage into other
sites, 43.33% were symptomatic (including Kawasaki dis-
ease with CAD in 5 patients, chest pain in 1 patient,
congenital CAF with CAD in 7 patients), 33.33% had spon-
taneous resolution and 16.67% were associated with Ka-
wasaki disease. When two groups of different drainage sites
were compared, there were no statistically significant dif-
ference in spontaneous resolution (p Z 0.819) and associ-
ated Kawasaki disease (p > 0.99). However, most patients
with CAF drainage into the MPA were clinically asymptom-
atic (p Z 0.018; Table 3).congenital coronary artery fistulas.
Acquired group
(n Z 23)
Congenital group
(n Z 99)
p
15:8 49:50 0.174
11.19 ± 1.02 12.69 ± 1.13 0.329
20.43 ± 6.32 29.97 ± 4.03 0.211
54.26 ± 8.65 39.87 ± 3.65 0.098
0/23 7/92 0.345
5/7 11/55 0.063
3/19 16/69 0.758
14/9 23/76 < 0.001
22/1 1/98 < 0.05
patients; congenital group, 33 patients).
1 patient; congenital group, 14 patients).
Table 2 Comparison of clinical manifestations of symptomatic and asymptomatic patients with coronary artery fistulas.
Symptomatic group
(n Z 32)
Asymptomatic group
(n Z 90)
p
Sex (male:female) 16:16 48:42 0.746
Body weight (kg) 15.13 ± 2.01 11.47 ± 1.04 0.088
Age (mo) 36.88 ± 7.84 25.08 ± 3.8 0.138
Continuous murmur or Grade 2e3/6 systolic murmur (yes/no) 6/26 1/89 0.001
Chest radiographya (cardiomegaly/normal) 8/14 8/48 0.03
Electrocardiographyb (abnormal/normal) 7/24 12/64 0.404
Spontaneous closure (yes/no) 11/21 26/64 0.562
Coronary artery fistula (acquired/congenital) 16/16 7/83 < 0.001
Associated with Kawasaki disease (yes/no) 17/15 6/84 < 0.05
a 44 patients did not undergo chest radiography (symptomatic group, 10 patients; asymptomatic group, 34 patients).
b 15 patients did not undergo electrocardiography (symptomatic group, 1 patient; asymptomatic group, 14 patients).
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Twenty-four patients had CADd17 with Kawasaki disease (1
of whom had congenital CAF, the result of fistula detection
before Kawasaki disease diagnosis) and seven with
congenital CAF post intervention. Compared with the initial
measurements, the CA size in these patients significantly
decreased after follow-up (4.17  0.41 mm vs.
2.94  0.2 mm; p < 0.001). Spontaneous CAF closure
occurred in 10 patients who also had CAD. Among all CAD
patients in the congenital group, the CA diameter exceeded
5 mm. Furthermore, three patients had fistulas, which
drained into the right ventricle, and four had fistulas that
drained into the right atrium. All of these patients under-
went percutaneous transcatheter intervention, and their
CA sizes decreased significantly after follow-up
(6.56  0.74 mm vs. 3.96  0.33 mm; p Z 0.012).Discussion
CAF is a rare anomaly, estimated to comprise only 0.2e0.4%
of congenital heart disease cases.1,11 Although most CAFs
are congenital, acquired CAF may occur, especially after
cardiac surgery, chest trauma, or Kawasaki disease.11e13
CAF presentations range from life threatening to asymp-
tomatic with spontaneous closure.1,14e15 In most literature
we reviewed, the incidence of symptomatic CAF ranged
from 30% to 55%, with symptoms including chest pain, ex-
ertional dyspnea, palpitations and symptoms of heart fail-
ure.1,3 Only 10e20% of pediatric CAF patients are
symptomatic.16,17 Most asymptomatic patients (80%) areTable 3 Comparison of clinical manifestations of different coro
CAF dra
MPA (n Z
Symptomatic/asymptomatic 19/73
Spontaneous closure (yes/no) 27/65
Associated with Kawasaki disease (yes/no) 18/74
CAF (acquired/congenital) 17/75
CAF Z coronary artery fistula; MPA Z main pulmonary artery.diagnosed with CAF during evaluation for a cardiac
murmur.1,2,9 However, in certain cases, when CAFs go un-
treated, severe complications may result, including CAD,
congestive heart failure, infective endocarditis, myocardial
infarction, ventricular arrhythmia and sudden death.7
In our literature review, we noted that some authors
recommend leaving CAF untreated in pediatric patients if
the shunt is very small; the rationale being that most CAFs
in childhood are associated with low morbidity and mor-
tality rates, and can be treated conservatively.5,9,11 Jaffe
et al18 concluded that small shunts tend to remain small,
and that pediatric CAF patients tend to remain asymp-
tomatic well into adulthood. Therefore, these authors
maintain that there is no urgent need for immediate CAF
closure in asymptomatic pediatric patients; with careful
monitoring, some fistulas may close spontaneously.1,5,9 If
spontaneous closure does not occur, or if patients go on to
develop symptoms, coronary dilatation or aneurysmal for-
mation, surgical or percutaneous intervention should then
be performed.2,8,11,15
However, other authors recommend early closure of
CAFs in childhood, regardless of the presence or absence of
symptoms.6e7,17,19 Shyam et al6 suggested closing all CAFs
because of the high incidence of late symptoms and com-
plications. In their study, 25 patients (48%) were symp-
tomatic, primarily at 18 years. Liberthson et al17
conducted a similar review of 174 patients and found that
30% were symptomatic. Specifically, among patients  20
years of age, 9% were symptomatic and 19% experienced
complications; among patients  20 years of age, 55% were
symptomatic and 63% experienced complications. In sum-
mary, the risk of symptoms or complicationsdincludingnary artery fistula (CAF) drainage sites.
inage to
92)
CAF drainage other
than MPA (n Z 30)
p
13/17 0.018
10/20 0.819
5/25 0.999
6/24 0.853
Outcome of coronary artery fistula in children 575congestive heart failure, pulmonary hypertension,
myocardial ischemia/infarction, fistula aneurysm rupture,
infective endocarditis and sudden deathdwas found to be
significantly higher in adulthood.20e22 The cardiac compli-
ance and the level of myocardial systolic function also
worsen with age in CAF. For these reasons, these authors
recommend performing elective ligation of CAFs as soon as
the diagnosis is established, before pediatric patients reach
adulthood and develop late symptoms and
complications.3,22
Considering these opposing opinions, it is clear that the
optimal approach for managing CAF in pediatric patients
remains controversial, particularly in patients who are
asymptomatic. We found that most patients in our study
were asymptomatic (73.77%). In addition, only seven
(5.74%) had a continuous or Grade 3/6 systolic heart
murmurdless than the incidence found in previous stud-
ies.5e9 Furthermore, we found that previous studies re-
ported > 65% of CAF patients with fistulas that drained
into the right side of the heart, 40e44% into the right
ventricle, 25e36% into the right atrium, 15e23% into the
pulmonary trunk, 7% into the coronary sinus, and 8e11%
into the left ventricle.6,9,23 However, in our study, the
MPA was the most common site of fistula drainage
(75.41%), followed by the RPA (7.38%), the right ventricle
(4.1%), the right atrium (3.28%), and the left ventricle
(0.82%). We detected fistula drainage to the main pul-
monary artery by measuring, via color Doppler, an
abnormal flow within the pulmonary artery during the
diastolic phase. In the past, this type of CAF was difficult
to detect, and few cases were mentioned in the literature
we reviewed. With the advanced sensitivity of echocar-
diography, we can now document the presence of even
tiny lesions more reliably.9,13,24e26
Previous studies we reviewed also estimated a low
likelihood of spontaneous closure, with documented inci-
dence rates of w1e2%.5,27 More recent reports have
documented higher spontaneous closure rates in small and
clinically silent fistulas.16 In our study, we measured a
spontaneous closure rate of 28.89% in asymptomatic pa-
tients; these patients remained asymptomatic during
follow-up. Patients in our study with either presenting
symptoms or dilated coronary arteries typically had either a
continuous or a Grade 3/6 systolic murmur. The acquired
CAF patients we studied had a higher fistula spontaneous
closure rate than those with congenital CAF (60.87% vs.
23.23%); most of our acquired CAF patients were also
categorized in the symptomatic group. This may be
explained by the fact that most had also been diagnosed
with Kawasaki disease; the severe vasculitis caused by Ka-
wasaki disease may result in both CAD and CAF. However,
after vessel inflammation dissipates, CAF may no longer
appear on echocardiographs.13
CAD in pediatric patients is uncommon, and is usually a
complication of either Kawasaki disease or CAF.2 In our
study, we found that CAD patients who underwent trans-
catheter or surgical intervention experienced a noticeable
decrease in CA size; however, their CAs still remained
larger than those of patients without CAD.3,28e30 All
changes observed in our patients on EKG or chest radiog-
raphy were nonspecific and not related to their clinical
outcomes. Ischemic changes are uncommon in children, butmay become more frequent with increasing age and may be
induced by an exercise tolerance test.9,30
In conclusion, with the enhanced sensitivity of echo-
cardiography, more cases of CAF in pediatric patients can
be detected than ever before. CAF-related complications
are very rare in these asymptomatic patients. Conse-
quently, management of CAF patients must depend upon
their related symptoms or complications. If patients have
small CAFs and are asymptomatic, conservative follow-up is
suggested and interventional procedures are likely unnec-
essary. With careful monitoring, some of these fistulas may
close spontaneously, particularly in cases of acquired CAF.
By contrast, our study revealed that congenital CAFs in
symptomatic patients usually had accompanying CAD, large
shunts, and continuous murmurs. Surgical ligation or
percutaneous transcatheter closure of the fistula should be
considered in patients with symptoms, persistent dilatation
of the proximal CA, or by the presence of a continuous or
Grade 3/6 systolic heart murmur.References
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